|
| |
A Guide
to Assay Development
Click to purchase:
A Guide to Assay Development
Description:
D&MD's Guide to Assay Development provides critical information to speed and
simplify the development and optimization of most technologies. This Guide
eliminates the tendency to "reinvent the wheel" by providing valuable tips that
incorporate the author's many years of hands-on experience in the field.
300+
Pages, 45+ Exhibits, Including Assay Development Checklists & 2 Examples of
Assay Troubleshooting
|
This Guide thoroughly evaluates the
capabilities, strengths, weaknesses, and expectations of leading
assays and assay technologies.
Assay development is often time consuming and frustrating. But
reliable, robust assays are key to every phase of pharmaceutical
development. D&MD's Guide to Assay Development provides
critical information to speed and simplify the development and
optimization of most technologies. This Guide eliminates the
tendency to "reinvent the wheel" by providing valuable tips that
incorporate the author's many years of hands-on experience in the
field.
This Guide provides the information
necessary to select and develop the appropriate assay for the task
at hand, including:
-
The most common and rapidly-growing assays in the drug discovery
and drug development industries.
-
Charts and tables cut through the sales hype and facilitate
comparisons of different assay types.
-
Tips and tricks learned over 15 years of professional experience
and collaborative work in laboratory assays.
-
The often neglected topics of biological sample matrix and
high-volume data analysis.
-
Step-by-step instructions and checklists for assay optimization,
validation, automation, scale-up, and miniaturization.
-
Emerging platforms, formats, and technologies for high-throughput
screening (HTS) and ultra-high-throughout screening (UHTS).
-
Detailed comparisons of technologies designed to help scientists
determine the best format to meet their assay needs.
-
Lists of instrument manufacturers and supply vendors-including
original references and historical developments, with resources
for finding detailed modern laboratory recipes.
|
|
|
|
The following professionals
involved in drug discovery, screening, lead generation, and assay
technology will greatly benefit from this Guide:
Directors, Lab Managers, Group Leaders, Senior
Scientists, Principal Scientists, Project Managers, Heads of
Research & Development, Quality Control Managers, and more
This Guide Will Answer
the Following Questions:
-
How does a scientist determine the best assay for a
particular application?
-
What questions must be asked and answered during
assay development?
-
What steps are involved in optimization and
validation of an assay?
-
How can a scientist determine that an assay is
fully optimized, sufficiently validated, and ready for full-scale
operation?
-
How can controls be used to provide the earliest
warning of assay problems?
-
How does sample throughput and assay
miniaturization really affect data quality and reagent
consumption?
-
Will migrating to a higher-density microplate
format improve throughput?
-
How do state-of-the-art assay instruments fail
during normal operation, and what can be done to minimize failure
and the impact of failure on operations?
-
What universal considerations are critically
important for every assay?
|
|
|
Table of Contents:
Executive Summary, Introduction, Common Assays, General Assay Design, Format,
Readout (Reporting Format), Validation, In Vitro Assays, Cell-Based Assays,
Automation Platforms, Emerging Technologies, Information Management, Appendices,
Bibliography
|
Table of Contents |
|
Section |
Summary |
|
1 |
Executive Summary |
|
2 |
Introduction |
|
2.1 |
Definitions |
|
2.1.1 |
Assays and Analytes |
|
2.1.2 |
Qualitative and Quantitative |
|
2.1.3 |
Targets |
|
2.1.4 |
Stains, Dyes, Tags, Labels, and Reporters |
|
2.1.5 |
Potentially Confusing Terminology |
|
2.2 |
Brief Historical Perspective |
|
2.2.1 |
Diagnostics |
|
2.2.2 |
Drug
Discovery |
|
2.3 |
Basic Issues |
|
2.3.1 |
Sampling |
|
2.3. |
2
Primary and Secondary Assays |
|
2.3.3 |
Confounding Analytes |
|
2.4 |
Drug Development and Manufacturing |
|
2.4.1 |
Impurities |
|
2.4.2 |
Therapeutics |
|
2.5 |
Miniaturization |
|
2.5.1 |
Microplates |
|
2.5.2 |
Arrays and Microarrays |
|
3 |
Common Assays |
|
3.1 |
Quantitation of Therapeutics and Other Compounds |
|
3.1.1 |
Weighing |
|
3.1.2 |
Extinction Coefficient |
|
3.1.3 |
Evaporative Light Scattering Detection |
|
3.1.4 |
Nuclear Magnetic Resonance |
|
3.1.5 |
Chemiluminescent Nitrogen Detection |
|
3.2 |
Microbial Contamination |
|
3.2.1 |
Culture Tests |
|
3.2.2 |
PCR
|
|
3.2.3 |
ELISA
|
|
3.3 |
Binding |
|
3.3.1 |
Molecular Size |
|
3.3.2 |
Biochemical Function |
|
3.3.3 |
Labeling |
|
3.4 |
Enzyme Assays |
|
3.4.1 |
Proteases |
|
3.4.2 |
Kinases and Phosphorylases |
|
3.5 |
G-Protein Coupled Receptors |
|
3.5.1 |
Cell
Culture Expression |
|
3.5.2 |
Promiscuous GPCR |
|
3.5.3 |
cAMP
|
|
3.5.4 |
Calcium and IP3 |
|
3.6 |
Ion Channels |
|
3.6.1 |
Ion
Flux |
|
3.6.2 |
Patch-Clamp |
|
3.6.3 |
Reporter Dyes |
|
3.6.4 |
Voltage Sensitive Dye Systems |
|
3.6.5 |
Membrane Binding Assays |
|
3.7 |
Toxicology and Pharmacology |
|
3.7.1 |
Ion
Channel Assays in Cardiac Toxicity |
|
3.7.2 |
Gene
Expression in ADME |
|
3.7.3 |
Hepatotoxicity |
|
3.8 |
Genetic Polymorphism |
|
3.8.1 |
Restriction Fragment Length Polymorphisms |
|
3.8.2 |
Hybridization Assays |
|
3.8.3 |
PCR
for SNP |
|
3.8.4 |
Single Base Extension |
|
4 |
General Assay Design |
|
4.1 |
Universal Considerations |
|
4.1.1 |
Precision 1 |
|
4.1.2 |
Optimal Reagent Amounts |
|
4.1.3 |
Standard Curves |
|
4.1.4 |
Multiplicity and Statistics |
|
4.1.5 |
Interpolation |
|
4.2 |
Nature of Analyte and Matrix |
|
4.2.1 |
Analyte Stability |
|
4.2.2 |
Separation and Enrichment |
|
4.2.3 |
Internal Standard "Spike" |
|
4.3 |
Assay Objectives |
|
4.3.1 |
Research, Development, or Process |
|
4.3.2 |
Budget |
|
4.3.3 |
Throughput |
|
4.3.4 |
Scalability |
|
4.3.5 |
Sensitivity |
|
4.3.6 |
Error
Tolerance |
|
5 |
Format |
|
5.1 |
Homogenous and Heterogeneous |
|
5.1.1 |
Pros
and Cons |
|
5.1.2 |
Heterogeneous Immobilization |
|
5.2 |
Direct and Indirect |
|
5.2.1 |
Second Mediators |
|
5.2.2 |
Second Antibodies |
|
5.2.3 |
Biotin-Avidin |
|
5.2.4 |
Enzyme Reporter Systems |
|
5.3 |
Agonists and Antagonists |
|
5.3.1 |
Competition |
|
5.4 |
In
Vitro and In Vivo |
|
5.4.1 |
In
Vitro Assays |
|
5.4.2 |
In
Vivo Assays |
|
5.4.3 |
Biological Material |
|
6 |
Readout (Reporting Format) |
|
6.1 |
Colorimetric and Fluorometric |
|
6.1.1 |
Colorimetric Assays |
|
6.1.2 |
Fluorometric Assays |
|
6.2 |
Radiometric |
|
6.2.1 |
Radiolabeling |
|
6.2.2 |
Radioimmunoassay |
|
6.2.3 |
Scintillation Proximity Assay |
|
6.3
|
Biological Growth |
|
6.3.1 |
Special Growth Media |
|
6.4 |
Other Readouts |
|
7 |
Validation |
|
7.1 |
Installation and Operation Qualification |
|
7.1.1 |
Instruments and Equipment |
|
7.1.2 |
Assay
Optimization |
|
7.1.3 |
Other
Variables |
|
7.2 |
Performance Qualification |
|
7.2.1 |
Instruments and Consumables |
|
7.2.2 |
Operation Re-Certification |
|
7.2.3 |
Assay
Parameters |
|
7.2.4 |
Data
Certification |
|
7.3 |
Scale-Up |
|
7.3.1 |
General |
|
7.3.2 |
Step-by-Step Process |
|
8 |
In Vitro Assays |
|
8.1 |
General |
|
8.1.1 |
Spectroscopy |
|
8.1.2 |
Protein Assays |
|
8.2 |
Enzyme Assays |
|
8.2.1 |
Enzyme Stability |
|
8.2.2 |
Proteases |
|
8.2.3 |
Kinases and Phosphorylases |
|
8.2.4 |
Enzyme SPA |
|
8.3 |
Binding |
|
8.3.1 |
Specificity |
|
8.3.2 |
Valence and Avidity |
|
8.3.3 |
Blocking and Washing |
|
8.4 |
Antibodies and Immunoassays |
|
8.4.1 |
Antibodies |
|
8.4.2 |
Immunoassays |
|
8.4.3 |
ELISAs |
|
8.4.4 |
"Classical" Immunoassays |
|
8.4.5 |
Fluorescence Quenching |
|
8.4.6 |
Fluorescence Polarization |
|
8.4.7 |
Scintillation Proximity Assay |
|
8.4.8 |
Other
Binding Assays |
|
8.5 |
Nucleic Acids |
|
8.5.1 |
General |
|
8.5.2 |
Polymerase Chain Reaction |
|
8.5.3 |
Hybridization Blots |
|
9 |
Cell-Based Assays |
|
9.1
|
General |
|
9.1.1 |
Pitfalls |
|
9.1.2 |
Controls |
|
9.2 |
Fixed Cells |
|
9.2.1 |
Fixing |
|
9.2.2 |
Fluorescence in Situ Hybridization |
|
9.2.3 |
Immunofluorescence Assay |
|
9.2.4 |
Staining and Counter-Staining |
|
9.3 |
Whole Cells |
|
9.3.1 |
Cell
ELISAs and ELISpots |
|
9.3.2 |
Cytotoxicity |
|
9.3.3 |
Surface Binding and Membrane Transport |
|
9.3.4 |
Trafficking and Translocation |
|
9.3.5 |
Nuclear Receptors |
|
9.3.6 |
Cell
Quantitation |
|
9.3.7 |
Vitality |
|
9.3.8 |
Motility |
|
9.3.9 |
Apoptosis |
|
9.3.10 |
SPA
in Microplates |
|
9.3.11 |
Fluorescence |
|
9.4 |
Flow Cytometry |
|
9.4.1 |
General |
|
9.4.2 |
Advantages and Limitations |
|
9.4.3 |
Fluorophore Selection |
|
9.4.4 |
Controls |
|
9.4.5 |
Gating |
|
9.4.6 |
Applications |
|
9.5 |
Lysates |
|
9.5.1 |
Gene
Expression |
|
9.5.2 |
Protein Expression (Gene Induction) |
|
9.6 |
Microscopy |
|
9.6.1 |
Stains |
|
9.6.2 |
Labels |
|
9.6.3 |
FISH
and IFA |
|
10 |
Automation Platforms |
|
10.1 |
Miniaturization |
|
10.1.1 |
Pros
and Cons |
|
10.1.2 |
Scaling |
|
10.2 |
Robotics |
|
10.2.1 |
Conveyors and Workstations |
|
10.2.2 |
Integrated and Modular |
|
10.2.3 |
Examples |
|
10.3 |
Liquid Handlers |
|
10.3.1 |
General Applications |
|
10.3.2 |
Delivery Size |
|
10.3.3 |
Calibration |
|
10.3.4 |
Cross-Contamination |
|
10.3.5 |
Pipet
Tips |
|
10.4 |
Cell Handling |
|
10.4.1 |
Culture |
|
10.4.2 |
Sample Prep |
|
10.5 |
Microplate Equipment |
|
10.5.1 |
Microplates |
|
10.5.2 |
Plate
Handlers |
|
10.5.3 |
Washers |
|
10.5.4 |
Bar
Codes |
|
10.5.5 |
Cleaning and Maintenance |
|
11 |
Emerging Technologies |
|
11.1 |
Automated Image Analysis |
|
11.1.1 |
General Issues |
|
11.1.2 |
Practical Considerations |
|
11.1.3 |
An
Example |
|
11.2 |
Higher Density Formats |
|
11.2.1 |
384-Well Plates |
|
11.2.2 |
High
Density Microplates |
|
11.2.3 |
Microarrays, Microfluidics, and Chips |
|
11.3 |
New Technologies |
|
11.3.1 |
Surface Plasmon Resonance |
|
11.3.2 |
Flow
Cytometry with Labeled Beads and Libraries |
|
11.3.3 |
Branched DNA Binding Assay |
|
11.3.4 |
Single Molecule Detection |
|
11.3.5 |
Virtual Screening |
|
12 |
Information Management |
|
12.1 |
Data Analysis |
|
12.1.1 |
Acquisition |
|
12.1.2 |
Signal-To-Background and Signal-To-Noise Ratios |
|
12.1.3 |
Precision and Accuracy |
|
12.1.4 |
Type
1 and Type 2 Error |
|
12.1.5 |
Random and Systematic Error |
|
12.1.6 |
Binning and Pooling |
|
12.2 |
Statistics |
|
12.2.1 |
Binding Constants |
|
12.2.2 |
Michaelis-Menten Equations |
|
12.2.3 |
Error
and Standard Error |
|
12.2.4 |
Correlation Coefficient |
|
12.2.5 |
Standard Deviation |
|
12.2.6 |
Coefficient of Variance |
|
12.2.7 |
Z'
Factor |
|
12.2.8 |
More
Complicated Statistics |
|
13 |
Appendices |
|
13.1 |
Resources for Detailed Protocols |
|
13.1.1 |
Orgs |
|
13.1.2 |
Journals and Other Commercial Publications |
|
13.2 |
Checklist for General Assay Development. |
|
13.3 |
Microarray Assay Checklist |
|
13.4 |
Vendors |
|
13.5 |
Examples of Troubleshooting |
|
13.5.1 |
In
Vitro |
|
13.5.2 |
In
Vivo |
|
14 |
Bibliography |
Date published:
3/1/2003
Number of pages:
300+
Category:
Drug Discovery
Industry:
Pharmaceutical & Biotech
Price Hard Copy
(US$):
$395.00
Interested in this
report:
peter.barfoot@bioportfolio.com
| |
|